The attack is a symptom. The acid is the problem.
Gout announces itself with a specificity that few conditions match: a single joint, usually the big toe, becomes so inflamed that even a bedsheet touching it is unbearable. That inflammation is caused by monosodium urate crystals depositing in joint tissue when uric acid in the blood exceeds what the body can dissolve. Most people treat the flare and move on. The uric acid level that caused it rarely gets the same attention.
Uric acid is the end product of purine metabolism. Purines are broken down in the liver, and uric acid is filtered out by the kidneys. When production outpaces excretion, either because you're producing too much or your kidneys are clearing too little, serum uric acid rises. The medical term is hyperuricemia, and it is defined as a serum uric acid level above 6.8 mg/dL in women and above 7 mg/dL in men. At those concentrations, urate crystals can form anywhere there is fluid, not just in joints.
What the kidneys are doing with your uric acid
Roughly 70 percent of uric acid is excreted through the kidneys. The other 30 percent exits through the gut. That renal dominance means the kidneys are the primary checkpoint, and the primary casualty when the system fails. Urate crystals can deposit directly in renal tubules, causing urate nephropathy. Chronic hyperuricemia also triggers an inflammatory cascade that damages the small blood vessels supplying the kidney, reducing filtration capacity over time.
A 2012 study published in the American Journal of Kidney Diseases, led by Zhu and colleagues using data from the US National Health and Nutrition Examination Survey, found that hyperuricemia was independently associated with a significantly higher prevalence of chronic kidney disease (CKD). The association held even after adjusting for hypertension, diabetes, and other confounders. The kidney does not need crystals to be damaged, sustained high uric acid levels alone are enough to accelerate filtration decline.
Creatinine, the standard marker on most Indian blood panels, often reads normal until the kidney has lost 50 to 60 percent of its filtering capacity. Uric acid rises earlier in the disease curve. A serum uric acid level that has been above 7 mg/dL for years, even without gout attacks, is a more sensitive early signal of renal stress than a normal creatinine reading is a guarantee of renal health.
Purines, diet, and what actually matters in an Indian kitchen
Purine content in food is real, but it is one variable among several, and it is frequently overstated. Red meat, organ meats like liver and kidney, shellfish, and alcohol, especially beer, are high-purine foods that also impair renal uric acid clearance. Fructose is a separate mechanism: it accelerates purine synthesis in the liver independent of dietary purine intake, which is why packaged fruit juices and sweetened drinks raise uric acid even when red meat is off the plate.
Dal and other legumes have moderate purine content, but population studies have not shown them to increase gout risk the way animal purines do. Dropping masoor dal from the diet of someone with hyperuricemia is unlikely to move the number meaningfully. Dropping daily alcohol and replacing packaged juice with water almost certainly will. The distinction matters because dietary advice for gout is frequently so broad it becomes unworkable.
Staying well hydrated keeps urine dilute and supports uric acid excretion. A urine output target of 2 to 2.5 litres per day is the standard clinical recommendation for patients with recurrent gout or uric acid kidney stones.
The numbers to ask for and what they mean
A standard metabolic panel in India typically includes creatinine and blood urea nitrogen but does not always include serum uric acid unless specifically requested. If you have had a gout attack, ask for uric acid alongside creatinine and eGFR (estimated glomerular filtration rate). eGFR gives a more direct measure of kidney filtering function than creatinine alone.
A serum uric acid above 9 mg/dL, or any level accompanied by recurrent gout attacks, tophi (urate deposits under the skin), or kidney stones, is the threshold at which most nephrologists and rheumatologists recommend urate-lowering therapy. Allopurinol, a xanthine oxidase inhibitor, is the most commonly prescribed first-line drug. It reduces uric acid production rather than increasing excretion, which matters in patients whose kidneys are already compromised.
Febuxostat is an alternative for patients who cannot tolerate allopurinol. Both drugs require dose adjustment in CKD. Starting urate-lowering therapy during an acute gout flare is generally avoided, it can prolong the attack, but the decision on timing should come from a physician, not a general rule.
The trajectory of your uric acid over multiple readings tells more than a single number. A level that was 7.2 mg/dL two years ago and is now 8.9 mg/dL without a change in diet is a different clinical picture than a stable 7.5 mg/dL that has not moved in five years. Ask your doctor for the trend, not just the current value.
Gout and kidney disease share a feedback loop that most people discover only after the kidney has already registered damage. Impaired kidneys clear less uric acid, raising serum levels further, which causes more renal inflammation, which impairs clearance further. Catching the uric acid number early, before the flare, before the creatinine climbs, is the only point in that loop where the direction can be changed.
